Jason Yap is a Senior Executive with over 18 years of experience in the Pharmaceutical and Biotechnology industries.
He has worked for a range of large, mid-size and pharma/biotech startups. Jason Yap is an experienced executive with a special focus on regulatory drug development, having overseen various early (pre-Phase I) and late stages (Phase II-III) development assets through to commercialization in global markets including the USA, EU and rest of the world. Additionally, Jason Yap has developed developmental expertise in diverse therapeutic areas such as oncology, rare diseases, autoimmune and cardiovascular diseases.
Jason Yap has an Executive MBA in General Management from the Thunderbird School of Global Management. Additionally, he holds a Masters Degree in Toxicology and Bachelor Degree in Biochemistry.
He has lived in Malaysia, UK and USA, and over the last ten years, in Switzerland.
